Literature DB >> 33330914

Association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Yan Chen1,2, Leila R Zelnick2,3, Ke Wang2,3, Ronit Katz2,3, Andrew N Hoofnagle2,4, Jessica O Becker4, Chi-Yuan Hsu5, Alan S Go6, Harold I Feldman7,8, Rupal C Mehta9, James P Lash10, Sushrut S Waikar11, L Hamm12, Jing Chen12, Tariq Shafi13, Bryan R Kestenbaum2,3.   

Abstract

BACKGROUND: The secretion of organic solutes by the proximal tubules is an essential intrinsic kidney function. The degree to which secretory solute clearance corresponds with the glomerular filtration rate (GFR) and potential metabolic implications of net secretory clearance are largely unknown.
METHODS: We evaluated 1240 participants with chronic kidney disease (CKD) from the multicenter Chronic Renal Insufficiency Cohort (CRIC) Study. We used targeted mass-spectrometry to quantify candidate secretory solutes in paired 24-h urine and plasma samples. CRIC study personnel measured GFR using 125I-iothalamate clearance (iGFR). We used correlation and linear regression to determine cross-sectional associations of secretory clearances with iGFR and common metabolic complications of CKD.
RESULTS: Correlations between iGFR and secretory solute clearances ranged from ρ  = +0.30 for hippurate to ρ = +0.58 for kynurenic acid. Lower net clearances of most secretory solutes were associated with higher serum concentrations of parathyroid hormone (PTH), triglycerides and uric acid. Each 50% lower kynurenic acid clearance was associated with a 21% higher serum PTH concentration [95% confidence interval (CI) 15-26%] and a 10% higher serum triglyceride concentration (95% CI 5-16%) after adjustment for iGFR, albuminuria and other potential confounders. Secretory solute clearances were not associated with statistically or clinically meaningful differences in serum calcium, phosphate, hemoglobin or bicarbonate concentrations.
CONCLUSIONS: Tubular secretory clearances are modestly correlated with measured GFR among adult patients with CKD. Lower net secretory clearances are associated with selected metabolic complications independent of GFR and albuminuria, suggesting potential clinical and biological relevance.
© The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  CKD complications; glomerular filtration rate; proximal tubular secretion; secretory solutes clearances

Year:  2020        PMID: 33330914      PMCID: PMC8237987          DOI: 10.1093/ndt/gfaa057

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  66 in total

1.  Renal Clearance of Mineral Metabolism Biomarkers.

Authors:  Adriana J van Ballegooijen; Eugene P Rhee; Sammy Elmariah; Ian H de Boer; Bryan Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-06-05       Impact factor: 10.121

2.  Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.

Authors:  Megan Rossi; Katrina L Campbell; David W Johnson; Tony Stanton; David A Vesey; Jeff S Coombes; Kassia S Weston; Carmel M Hawley; Brett C McWhinney; Jacobus P J Ungerer; Nicole Isbel
Journal:  Arch Med Res       Date:  2014-04-18       Impact factor: 2.235

Review 3.  Endocrine and metabolic regulation of renal drug transporters.

Authors:  Lindsay L Yacovino; Lauren M Aleksunes
Journal:  J Biochem Mol Toxicol       Date:  2012-08-29       Impact factor: 3.642

4.  Protein-Bound Uremic Toxins from Gut Microbiota and Inflammatory Markers in Chronic Kidney Disease.

Authors:  Natália A Borges; Amanda F Barros; Lia S Nakao; Carla J Dolenga; Denis Fouque; Denise Mafra
Journal:  J Ren Nutr       Date:  2016-11       Impact factor: 3.655

5.  Tubular Secretion in CKD.

Authors:  Astrid M Suchy-Dicey; Thomas Laha; Andrew Hoofnagle; Rick Newitt; Tammy L Sirich; Timothy W Meyer; Ken E Thummel; N David Yanez; Jonathan Himmelfarb; Noel S Weiss; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2015-11-27       Impact factor: 10.121

6.  Verapamil prevents chronic renal failure-induced abnormalities in lipid metabolism.

Authors:  M Akmal; S Perkins; S E Kasim; H Y Oh; M Smogorzewski; S G Massry
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

7.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

8.  Parathyroid hormone clearance in man.

Authors:  S B Oldham; E J Finck; F R Singer
Journal:  Metabolism       Date:  1978-08       Impact factor: 8.694

9.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

10.  Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations.

Authors:  Henricus A M Mutsaers; Lambertus P van den Heuvel; Lauke H J Ringens; Anita C A Dankers; Frans G M Russel; Jack F M Wetzels; Joost G Hoenderop; Rosalinde Masereeuw
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

View more
  1 in total

1.  Clinical Effect of Mudan Granule on Peripheral Neuritis Caused by Chronic Renal Insufficiency.

Authors:  Xinle Li; Huan Zheng; Zhihong Zhou; Zhao Li; Xiurong Zhou; Ming Zheng
Journal:  Comput Math Methods Med       Date:  2022-03-31       Impact factor: 2.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.